All sites C00-96,D32-33,D42-43,D45-47,D76 147 89.4 2.3 4.1 0.7 3.5
Mouth, pharynx C00-14 3 93.8 6.3 - - -
  Lip C00 0 100.0 - - - -
  Tongue C02 1 100.0 - - - -
  Mouth, other C03-06 1 100.0 - - - -
  Salivary glands C07-08 0 50.0 50.0 - - -
  Pharynx C01,C09-14 0 100.0 - - - -
Digestive organs C15-26 28 82.1 2.1 7.9 2.1 5.7
  Oesophagus C15 0 100.0 - - - -
  Stomach C16 3 87.5 - - 6.3 6.3
  Small intestine C17 0 100.0 - - - -
  Colon C18 7 100.0 - - - -
  Rectum, rectosigmoid C19-20 4 100.0 - - - -
  Anus C21 0 100.0 - - - -
  Liver C22 2 83.3 - - 8.3 8.3
  Gallbladder, bile ducts C23-24 2 50.0 20.0 20.0 - 10.0
  Pancreas C25 7 64.9 2.7 18.9 2.7 10.8
  Other digestive organs C26 1 40.0 - 40.0 - 20.0
Respiratory organs C30-39 10 64.0 14.0 12.0 2.0 8.0
  Nose, sinuses C30-31 - - - - - -
  Larynx, epiglottis C32 0 50.0 - - - 50.0
  Lung, trachea C33-34 9 67.4 15.2 10.9 2.2 4.3
  Mediastinum, pleura C38 0 - - 100.0 - -
Bone C40-41 0 - - 100.0 - -
Melanoma of the skin C43 4 100.0 - - - -
Skin, non-melanoma C44 5 100.0 - - - -
Mesothelioma C45 0 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 1 75.0 - - - 25.0
Breast C50 49 99.2 - - - 0.8
Female genital organs C51-58 17 92.9 1.2 3.6 - 2.4
  Cervix uteri C53 2 87.5 12.5 - - -
  Corpus uteri C54 7 100.0 - - - -
  Uterus, other C55,C58 - - - - - -
  Ovary C56 6 87.1 - 6.5 - 6.5
  Other female genital C51-52,C57 2 90.9 - 9.1 - -
Urinary organs C64-68 8 92.9 - 7.1 - -
  Kidney C64 5 88.5 - 11.5 - -
  Bladder and urinary tract2 C65-68 3 100.0 - - - -
Eye C69 - - - - - -
Brain, central nervous system C70-72,D32-33,D42-43 4 86.4 - 13.6 - -
Thyroid gland C73 3 100.0 - - - -
Other endocrine glands C74-75 0 100.0 - - - -
Illdefined or unknown C76,C80 4 66.7 5.6 16.7 5.6 5.6
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 10 76.5 7.8 - - 15.7
  Hodgkin lymphoma C81 0 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 5 100.0 - - - -
  Malignant immunoproliferative diseases C88 - - - - - -
  Myeloma and other plasma cell tumors C90 1 33.3 16.7 - - 50.0
  Leukaemia C91-95 2 60.0 30.0 - - 10.0
  Myelodysplastic syndromes D46 1 75.0 - - - 25.0
  Myeloproliferaitive neoplasms D45,D47 1 25.0 - - - 75.0
Not included above
  Carcinoma in situ of the breast D05 3 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 7 100.0 - - - -
  Borderline tumour of the ovary D39 2 100.0 - - - -
  Basal cell carcinoma of the skin 62 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.